Benzinga | Oct 5, 2021 08:47AM EDT

Aditxt Signs Transaction Agreement To Acquire Subsidiary Of AiPharma

Aditxt Signs a Transaction Agreement to Acquire AiPharma, Rights Holder of Antiviral Tablet Avigan/Reeqonus/Qifenda Used in the Treatment of Over 1.5 Million COVID-19 Patients Outside the U.S. and Canada